Jahn U, Thiele K
Biology and Research Department, Siegfried Ltd., Zofingen, Switzerland.
Arzneimittelforschung. 1988 Apr;38(4):507-8.
It has been demonstrated that the nonsteroidal antiinflammatory agent azapropazone (Prolixan) as well as its principal 8-hydroxy-metabolite have distinct xanthine oxidase inhibitory activity. The pharmacological spectrum of this compound has thus shown an interesting extension.
已证实非甾体抗炎药阿扎丙宗(Prolixan)及其主要的8-羟基代谢物具有明显的黄嘌呤氧化酶抑制活性。因此,该化合物的药理谱显示出有趣的扩展。